Switch to:
More From Other Websites
Dodge & Cox's Stock Fund 4th Quarter Commentary Jan 16 2017
Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst Jan 12 2017
European Pharma Shares Hammered After Trump Press Conference Attack Jan 12 2017
Bristol-Myers and AstraZeneca Take Beatings Jan 11 2017
2 Stocks For a Trump-ed Up Pharma Market Jan 11 2017
European stocks trim gains after Trump comments send drug stocks lower Jan 11 2017
Merck leapfrogs rivals in lung cancer drug combination race Jan 11 2017
Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost? Jan 11 2017
Can AstraZeneca (AZN) Be a Solid Choice for Value Investors? Jan 10 2017
[$$] Chance for an agile new drug approval system Jan 09 2017
Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline Jan 09 2017
Bullish and Bearish Reversals in the Market Jan 09 2017
Shell, AstraZeneca Could Surprise in 2017, Credit Suisse Says Jan 05 2017
Here's Why General Motors Is One of Wednesday's Most Active Stocks Jan 04 2017
AstraZeneca PLC (ADR) (AZN) Planning Tagrisso Label Expansion To Shore Up Earnings Jan 03 2017
AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How Jan 03 2017
Credit Suisse, AstraZeneca among top BofA-ML's top European picks for first quarter Jan 03 2017
Credit Suisse, AstraZeneca among top BofA-ML's top European picks for first quarter Jan 03 2017
2 healthcare stocks that could make you rich in 2017 Jan 03 2017
AstraZeneca’s Lynparza Is Still a Leading PARP Inhibitor in 2016 Jan 02 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK